About Perfluorohexyloctane API
Therapeutic Category眼科
CAS Number
133331-77-8
API Technology
Synthetic
Dose Form
Ophthalmic Solution
Dr Reddy's Development Status
Under Development
Mechanism of Action
Perfluorohexyloctane mediates its actions in the lipid layer and meibomian glands. While the exact mechanism of action is not fully understood, perfluorohexyloctane is believed to interact with the air-liquid interface of the tear film and form a monolayer, preventing the evaporation of the aqueous phase of the tears.
Indication
MIEBO™ (perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease (DED). Instill one drop of MIEBO four times daily into affected eye(s). Contact lenses should be removed prior to and for at least 30 minutes after the administration of MIEBO.
Related APIs
利他司特
眼科
曲伏前列素
眼科
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
FAQs
Perfluorohexyloctane is used to treat dry eye disease
-
Ophthalmic solution, 100% perfluorohexyloctane
-
Store at 15°C to 25°C (59°F to 77°F)
免责声明
本網站上的任何信息，包括對任何產品或服務的任何提及，均不構成銷售要約或被解釋為代表銷售要約。受有效專利保護的產品不得提供或供應用於商業用途。但是，在某些情況下，雷迪博士可自行決定並根據當地法律要求，在存在此類監管豁免的任何地方，提供此類產品的研究數量，以根據《印度專利法》第 107A 條（Bolar 豁免）進行監管提交。購買者應對其各自市場的產品或服務（包括專利情況）進行獨立評估，並對所有與專利相關的責任負責。 Dr. Reddy's 不承擔任何明示或暗示的保證，包括但不限於適銷性、適用於特定用途和非侵權的保證。